The Role of Polymorphic Variants of Gene Components of the PTEN/PI3K/AKT Signaling Pathway in the Development of Prostate Cancer

被引:0
作者
Gilyazova, I. R. [1 ]
Ivanova, E. A. [1 ]
Bermisheva, M. A. [1 ]
Loginova, M., V [2 ]
Asadullina, D. D. [1 ]
Ishemgulov, R. R. [2 ]
Mustafin, A. T. [2 ]
Pavlov, V. N. [2 ]
Khusnutdinova, E. K. [1 ,2 ]
机构
[1] Russian Acad Sci, Inst Biochem & Genet, Ufa 450054, Russia
[2] Bashkir State Med Univ, Ufa 450008, Russia
关键词
prostate cancer; polymorphic variants of genes; PTEN; PI3K; AKT pathway; PTEN; MTOR; RISK; PI3K; P53;
D O I
10.1134/S1022795422070055
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
The aim of this study was to search for associations of genotypes and alleles of polymorphic loci of the PTEN/PI3K/AKT pathway genes rs2494750 of AKT1, rs2735343, rs2299941, rs10490920 of PTEN, rs17878362 of TP53, and rs2699887 of PIK3CA with the risk of prostate cancer development. As a result of comparison allele and genotype frequencies between the general sample of prostate cancer patients and the control group of healthy individuals, it was found that the CG genotype of the polymorphic locus rs2735343 of PTEN is associated with an increased risk of developing the disease (OR = 1.38, 95%CI = 1.02-1.87, p = 0.04), whereas the GG genotype showed a decrease in the frequency of occurrence in the group of patients compared with the control (OR = 0.74, 95%CI = 0.55-0.99, p = 0.05). When stratifying the group of patients with prostate cancer, depending on histopathological characteristics, it was revealed that the rs2735343*C allele is associated with an increased risk of bilateral lesions of both prostate lobes and invasion of seminal vesicles. With allowance for further validating studies, the results of this work can be used to create a panel of molecular markers for disease prognosis and assessment of tumor characteristics.
引用
收藏
页码:844 / 849
页数:6
相关论文
共 21 条
  • [1] PTEN Loss in a Prostate Cancer Cohort From Jordan
    Al Bashir, Samir
    Alzoubi, Abdallah
    Alfaqih, Mahmoud A.
    Kheirallah, Khalid
    Smairat, Aya
    Haddad, Husam
    Al-Dwairy, Ahmad
    Fawwaz, Baha A. B.
    Alzoubi, Mazhar
    Trpkov, Kiril
    [J]. APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2020, 28 (05) : 389 - 394
  • [2] A Functional Variant in the MTOR Promoter Modulates Its Expression and Is Associated with Renal Cell Cancer Risk
    Cao, Qiang
    Ju, Xiaobing
    Li, Pu
    Meng, Xiaoxin
    Shao, Pengfei
    Cai, Hongzhou
    Wang, Meilin
    Zhang, Zhengdong
    Qin, Chao
    Yin, Changjun
    [J]. PLOS ONE, 2012, 7 (11):
  • [3] Association of Single-Nucleotide Polymorphisms in Monoubiquitinated FANCD2-DNA Damage Repair Pathway Genes With Breast Cancer in the Chinese Population
    Chen, Fei-Yu
    Wang, Hao
    Li, Hui
    Hu, Xue-Li
    Dai, Xu
    Wang, Shou-Man
    Yan, Guo-Jiao
    Jiang, Ping-Lan
    Hu, Yuan-Ping
    Huang, Juan
    Tang, Li-Li
    [J]. TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2018, 17
  • [4] Genetic Variations in a PTEN/AKT/mTOR Axis and Prostate Cancer Risk in a Chinese Population
    Chen, Jiawei
    Shao, Pengfei
    Cao, Qiang
    Li, Pu
    Li, Jie
    Cai, Hongzhou
    Zhu, Jian
    Wang, Meilin
    Zhang, Zhengdong
    Qin, Chao
    Yin, Changjun
    [J]. PLOS ONE, 2012, 7 (07):
  • [5] Divergence of P53, PTEN, PI3K, Akt and mTOR expression in tonsillar cancer
    Chun, Sang Hoon
    Jung, Chan-Kwon
    Won, Hye Sung
    Kang, Jin-Hyoung
    Kim, Yeon-Sil
    Kim, Min-Sik
    [J]. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2015, 37 (05): : 636 - 643
  • [6] Genomic Markers in Prostate Cancer Decision Making
    Cucchiara, Vito
    Cooperberg, Matthew R.
    Dall'Era, Marc
    Lin, Daniel W.
    Montorsi, Francesco
    Schalken, Jack A.
    Evans, Christopher P.
    [J]. EUROPEAN UROLOGY, 2018, 73 (04) : 572 - 582
  • [7] de Nóbrega M, 2020, GENET MOL BIOL, V43, DOI [10.1590/1678-4685-GMB-2018-0329, 10.1590/1678-4685-gmb-2018-0329]
  • [8] Germline variants in IL4, MGMT and AKT1 are associated with prostate cancer-specific mortality: An analysis of 12,082 prostate cancer cases
    FitzGerald, L. M.
    Zhao, S.
    Leonardson, A.
    Geybels, M. S.
    Kolb, S.
    Lin, D. W.
    Wright, J. L.
    Eeles, R.
    Kote-Jarai, Z.
    Govindasami, K.
    Giles, G. G.
    Southey, M. C.
    Schleutker, J.
    Tammela, T. L.
    Sipeky, C.
    Penney, K. L.
    Stampfer, M. J.
    Gronberg, H.
    Wiklund, F.
    Stattin, P.
    Hugosson, J.
    Karyadi, D. M.
    Ostrander, E. A.
    Feng, Z.
    Stanford, J. L.
    [J]. PROSTATE CANCER AND PROSTATIC DISEASES, 2018, 21 (02) : 228 - 237
  • [9] Confirmation of genetic variants associated with lethal prostate cancer in a cohort of men from hereditary prostate cancer families
    Karyadi, Danielle M.
    Zhao, Shanshan
    He, Qianchuan
    McIntosh, Laura
    Wright, Jonathan L.
    Ostrander, Elaine A.
    Feng, Ziding
    Stanford, Janet L.
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2015, 136 (09) : 2166 - 2171
  • [10] Endometrial cancer and genetic variation in PTEN, PIK3CA, AKT1, MLH1, and MSH2 within a population-based case-control study
    Lacey, James V., Jr.
    Yang, Hannah
    Gaudet, Mia M.
    Dunning, Alison
    Lissowska, Jolanta
    Sherman, Mark E.
    Peplonska, Beata
    Brinton, Louise A.
    Healey, Catherine S.
    Ahmed, Shahana
    Pharoah, Paul
    Easton, Douglas
    Chanock, Stephen
    Garcia-Closas, Montserrat
    [J]. GYNECOLOGIC ONCOLOGY, 2011, 120 (02) : 167 - 173